Neurology
A Blood Test Can See Risk. Policy Cannot Yet Hold It.
A JAMA study shows that plasma p-tau217 helps predict Alzheimer’s progression in cognitively unimpaired older adults. The science is moving fast. The ethics and policy are not.
Post-Stroke Cognitive Screening Needs Local Tools
Europe’s Stroke Plan Turns Speed Into a Policy Test
Parkinson’s Research Moves From Tracking Progression to Defining Biology
MS Monitoring Starts Moving Beyond the MRI Bottleneck
Latin America Challenges the Dementia Biomarker Evidence Gap
China’s Alzheimer’s Blood-Test Rollout Turns Diagnosis Into an Access Market
Alzheimer’s Blood Testing Moves Toward Routine Care
Alzheimer’s Drugs Force NICE Back Into the Value Debate
Europe Starts Treating Brain Health as System Resilience
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.